Back تحالف ابتكارات التأهب الوبائي Arabic Coalició per a les Innovacions en Preparació per Epidèmies Catalan Koalice pro inovativní epidemickou připravenost Czech Coalition for Epidemic Preparedness Innovations Danish Coalition for Epidemic Preparedness Innovations German Coalición para las Innovaciones en Preparación para Epidemias Spanish ائتلاف برای نوآوری‌های آمادگی همه‌گیری Persian Coalition pour les innovations en matière de préparation aux épidémies French Koalisi Inovasi Kesiapsiagaan Epidemi ID Coalizione per le innovazioni nella preparazione alle epidemie Italian

Coalition for Epidemic Preparedness Innovations

Coalition for Epidemic Preparedness Innovations
AbbreviationCEPI
FormationJanuary 2017 (2017-01)
Founders
Founded atDavos, Switzerland[3]
PurposeFund vaccine development[3]
HeadquartersOslo, Norway
Locations
Chief executive
Richard J. Hatchett
Key people
Jane Halton (Chair)
Staff (2020)
68[4]
WebsiteCEPI.net
Launch of the Coalition for Epidemic Preparedness Innovations, CEPI in 2017 at the World Economic Forum in Davos, Switzerland.

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).[4][5]

CEPI is focused on the World Health Organization's (WHO) "blueprint priority diseases", which include: the Middle East respiratory syndrome-related coronavirus (MERS-CoV), the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen "Disease X".[6][5] CEPI investment also requires "equitable access" to the vaccines during outbreaks, although subsequent CEPI policy changes may have compromised this criterion.[7] In 2022, CEPI adopted a vision for the world to be able to respond to a pandemic threat with a new vaccine within 100 days.[8]

CEPI was conceived in 2015 and formally launched in 2017 at the World Economic Forum (WEF) in Davos, Switzerland. It was co-founded and co-funded with US$460 million from the Bill and Melinda Gates Foundation, the Wellcome Trust,[3] and the governments of India and Norway, and was later joined by the European Union (2019) and the United Kingdom (2020).[3][5] CEPI is headquartered in Oslo, Norway.[4]

  1. ^ a b c d e "A global coalition to create new vaccines for emerging infectious diseases". cepi.net. January 18, 2017. Archived from the original on March 22, 2021. Retrieved March 9, 2021. CEPI is a direct response to calls from four independent expert reports into the Ebola epidemic for a new system for stimulating the development of vaccines against epidemic threats. It was founded by the governments of India and Norway, the Bill & Melinda Gates Foundation, Wellcome and the World Economic Forum, which has played a key convening role, bringing together stakeholders at the 2016 Davos meeting and other events.
  2. ^ "Who we are". cepi.net. Archived from the original on June 11, 2020.
  3. ^ a b c d Cite error: The named reference FT was invoked but never defined (see the help page).
  4. ^ a b c Peter Coy (February 13, 2020). "The Road to a Coronavirus Vaccine Runs Through Oslo". Bloomberg News. Archived from the original on March 20, 2020. Retrieved March 7, 2020.
  5. ^ a b c Cite error: The named reference ER was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference BUND was invoked but never defined (see the help page).
  7. ^ Cite error: The named reference Big_pharma was invoked but never defined (see the help page).
  8. ^ "CEPI, UK Government, and Life Sciences Industry unite around 100 Days Mission". CEPI. March 8, 2022. Archived from the original on August 15, 2023. Retrieved August 15, 2023.
From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by razib.in